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An Australian longitudinal pilot study
examining health determinants of cardiac
outcomes 12 months post percutaneous
coronary intervention
Karen-leigh Edward1,2* , John Stephenson1,2, Jo-Ann Giandinoto1, Andrew Wilson3, Robert Whitbourn3,
Jack Gutman3 and Andrew Newcomb3
Abstract
Background: Percutaneous coronary intervention (PCI) is a very common revascularisation procedure for coronary
artery disease (CAD). The purpose of this study was to evaluate cardiac outcomes, health related quality of life
(HRQoL), resilience and adherence behaviours in patients who have undergone a PCI at two time points (6 and
12 months) following their procedure.
Methods: A longitudinal pilot study was conducted to observe the cardiac outcomes across a cohort of patients
who had undergone a percutaneous coronary intervention (PCI). Participants who had undergone PCI 6 months
prior were invited. Those participants who met the inclusion criteria and provided consent then completed a
telephone survey (time point 1). These participants were then contacted 6 months later (i.e. 12 months post-intervention,
time point 2) and the measures were repeated.
Results: All patients (n = 51) were recorded as being alive at time point 1. The multiple model indicated that controlling
for other factors, gender was significantly associated with a linear combination of outcome measures (p = 0.004). The
effect was moderate in magnitude (partial-η2 = 0.303), where males performed significantly better than females 6 months
after the PCI procedure physically and with mood. Follow-up univariate ANOVAs indicated that gender differences were
grounded in the scale measuring depression (PHQ9) (p = 0.005) and the physical component score of the
short form measuring HRQoL (SF12-PCS) (p = 0.003). Thirteen patients were lost to follow-up between time
points 1 and 2. One patient was confirmed to have passed away. The pattern of correlations between
outcome measures at time point 2 revealed statistically significant negative correlation between the PHQ
instrument and the resilience scale (CD-RISC) (r = -0.611; p < 0.001); and the physical component score of the
SF-12 instrument (r = -0.437; p = 0.054).
Conclusions: Men were performing better than women in the 6 months post-PCI, particularly in the areas of
mood (depression) and physical health. This pilot results indicate gender-sensitive practices are recommended
particularly up to 6 months post-PCI. Any gender differences observed at 6 month appear to disappear at
12 months post-PCI. Further research into the management of mood particularly for women post-PCI is
warranted. A more detailed inquiry related to access/attendance to secondary prevention is also warranted.
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Background
Cardiovascular disease (CVD) has over the last decade
emerged as the single most important cause for death
worldwide [1]. Two recent international studies, the
INTERHEART study in 2005 and the INTERSTROKE
study in 2010 have confirmed that in both developing
and developed countries, the risk factors for CVD in-
clude: smoking, hypertension, abdominal obesity, lack of
physical activity, abnormal blood lipid profiles, diabetes,
alcohol intake, psychosocial factors and a diet deficient
in fruits, vegetables and fish [2, 3]. Percutaneous coron-
ary intervention (PCI) is a very common revascularisa-
tion procedure for coronary artery disease (CAD), and
indications for PCI include myocardial infarction (MI),
stable and unstable angina pectoris (SAP and UAP re-
spectively). In 2000, the age-standardised ratio of PCI
procedures in males compared to females was around
3.1 to 1; this is despite males experiencing heart attacks
at only twice the rate of females [4]. Irrespective of re-
cent advances in surgical technology, PCI is associated
with a range of adverse post-procedural complications,
including acute bleeding, cardiac events, vascular com-
plications and mortality [5–7].
A significant proportion of PCI patients also experience
mental health issues, although the direction of this rela-
tionship is unclear. Anxiety and depression are prevalent
in 25-50 % of CAD patients [8–10] and are associated
with readmission for further cardiovascular morbidity
[9, 11, 12], decreased health-related quality of life and
mortality [10, 13]. There is evidence to suggest that
levels of anxiety and depression in the majority of
PCI patients remain relatively stable 12 months post-
procedure, and baseline levels of anxiety and depression are
associated with either symptom improvement or deterior-
ation among those who experience changes to distress [14].
Research findings are inconclusive as to the impact of
PCI on quality of life post-procedure. Some evidence
indicates patients over the age of 70 years are more
likely to experience deteriorating and poorer mental and
physical health-related quality of life than those under
70 years at 36 months post-intervention, irrespective of
adverse events during outcomes [15]. The impact of psy-
chopathology such as anxiety and depression is known
to increase risk of readmission [11] and mortality [13],
but little is known about the efficacy of psychological
interventions on long-term outcomes of PCI. The short
term impacts (<6 months) of coronary care for patients
indicates HRQoL concerns should not drive revasculari-
sation decisions [16], that mood can predict worsening
heart health [17, 18] and QoL should be considered in
future research in order to inform practice decisions
with this group of patients [19]. There appears to be no
studies that have examined the notion of personal resili-
ence in this group of patients.
The aim of this longitudinal prognostic study was to
evaluate cardiac outcomes, HRQoL, personal resilience,
mental health and adherence behaviours in patients who
have had undergone a PCI measured at two time points
(6 months and 12 months) post-intervention. The objec-
tives of this study were to (1) inform clinical care prac-
tice of the care of patients who undergo PCI, and (2)
provide pilot information of patients related to QoL,
medication adherence behaviours, personal resilience
and mental health post a PCI.
Methods
Research design
A longitudinal pilot study design was undertaken. Ob-
servational research, such as this study allowed the use
of repeated measures of the same cohort over 12 months.
The benefit of this type of study is the ability to assess
the significance of predictors of outcomes post-PCI.
Participants and recruitment
Sampling
The study aimed to recruit a total of 49 participants. As
a pilot, the study was not powered to detect significant
effects or was subject to a formal sample size calcula-
tion. However, a sample size was desired which would
allow the assessment of incidence rates with a 95 % con-
fidence interval with +/- 10 % precision (i.e. to have
95 % confidence that the estimated rate was within 10 %
of its true value in the population) assuming a preva-
lence of hospital readmission of about 15 %. The sample
size also provided sufficient power to show that the
correlation between continuously distributed variables
(adherence, QOL etc.) and was statistically significant
if the correlation coefficient was ≥ 0.39 and provided
sufficient power to test 3-4 variables in multiple regression
models without compromising stability of estimates.
Exclusion criteria
Participants were excluded from the study if they were
under the age of 18 years, were unable to give informed
consent or English was not their first language.
Ethics, consent and permissions
Ethical clearance was obtained from both the hospital
(St Vincent’s Hospital Melbourne) and university
(Australian Catholic University) Human Research Ethical
Committees (protocol numbers LRR 020/13 and 2014
75 V respectively). Informed verbal consent was obtained
before data collection was undertaken. Consent to publish
findings in aggregated formats was obtained in the con-
sent process for all participants.
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Recruitment
Participants were identified via a database. This database
is called The Victorian Cardiac Outcomes Registry
(VCOR) and became operational in December 2012 as a
tool to help improve safety and quality of healthcare
provided to cardiovascular patients in the state of Victoria.
The collection of data, coordinated by the Victorian
Cardiac Clinical Network, and jointly funded by Victorian
Department of Health and Medibank Private, invited all
public and private health services that perform PCI to join
VCOR. St Vincent’s Private Hospital Melbourne was the
participating site in the original VCOR collection and
ethics approval was obtained for the use of this database
as a source of recruitment for our study. Participants were
invited to participate consecutively using the database
contact details and after providing informed consent by
the research interviewer completing the questionnaire
with participants, they were enrolled in the study. Recruit-
ment took place between 1/2014 and 11/2014.
Data collection
Data was collected via a telephone interview at both
time points (6 months and 12 months post-PCI). To
evaluate lifestyle cardiac risk factors, patients were asked
about their tobacco use, physical activity, diet, cholesterol/
lipids (total cholesterol above 5.5 mmol/L is considered
high), and about any weight gain. Patients were also asked
about their adherence to cardiac rehabilitation, and all
cause readmissions. Mortality was recorded if this had
occurred (see demographic information Table 1).
Adherence was measured using the Brief Medication
Questionnaire (BMQ). This self-report tool for monitoring
adherence is used to identify patients who need assistance
with their medications, assessing patient concerns, and
evaluating new programs. The tool includes a 5-item Regi-
men Screen that asks patients how they took each medica-
tion in the past week, a 2-item Belief Screen that asks
about drug effects and bothersome features, and a 2-item
Recall Screen about potential difficulties remembering.
Validity was assessed in 20 patients using the Medication
Events Monitoring System (MEMS). Results varied by
type of non-adherence, with the Regimen and Belief
Screens having 80–100 % sensitivity for “repeat” non-
adherence and the Recall Screen having 90 % sensitivity
for “sporadic” non-adherence. The BMQ appears more
sensitive than existing tools and may be useful in identify-
ing and diagnosing adherence problems [20].
Depression was evaluated using the Patient Health
Questionnaire (PHQ9) [21]. The sensitivity and specifi-
city of the PHQ9 is 83 and 92 % respectively if the scaled
response is requested as in the current investigation
(i.e. not at all = 0, several days = 1, more than half the
days = 2 and nearly every day = 3). The PHQ is positive if
the participant scores 3 or more points.., Minor depression
Table 1 Demographics and Health Information
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was defined to be given by a score between 5 and 9, and
severe depression was defined to be given by a score of 20
or more.
To measure resilience, the Connor-Davidson resilience
scale (CD-RISC) was used. The original CD-RISC is a
25-item scale assessing resilience during the last month,
with higher scores indicating higher resilience capacity
[22]. Each item is rated on a 5-point range of responses
from not true at all (0) to true nearly all time (4). The
total score ranges from 0–100. The CD-RISC has been
tested in the general population, as well as in clinical
samples, and demonstrates excellent psychometric
properties, with good internal consistency and test–retest
reliability. The scale exhibits validity relative to other mea-
sures of resilience. The CD-RISC is a brief, self-rated
measure of resilience that can measure resilience in the
context of health status.
The SF-12 was used to evaluate health related quality
of life. The SF-12 comprises: two questions about physical
functioning; two questions on role limitations because of
physical health problems; one question about bodily pain;
one question related to general health perceptions; one
question on vitality, energy/fatigue; one question on social
functioning; two questions about role limitations because
of emotional problems; and two questions on general
mental health. The 12 items on the SF-12 are summarized
in two weighted summary scales - mental health score
(MCS) and physical health score (PCS) - where lower
scores indicate more severe disability [23]. The SF12 -
PCS and MCS component summary scales – were scored
using a norm-based method. Regression weight for the
PCS and the MCS are derived from the United States of
America population [24].
Data analysis
The sample was summarised descriptively. The following
outcome measures were considered: resilience (as mea-
sured by the Connor-Davidson resilience scale (CD-
RISC)) [22]; depression (as measured by the Patient
Health Questionnaire (PQ-9)) [21]; adherence (as mea-
sured by the Brief Medication Questionnaire (BMQ))
[20] and quality of life (as measured by the MCS and
PCS sub-scales of the SF-12 questionnaire) [23]. The fol-
lowing variables collected on patients were initially con-
sidered for their association with the outcome measures at
each time point: gender, age, hypertension, tobacco use,
raised blood glucose (diabetes), physical activity, diet,
cholesterol/lipid levels, and weight. Additional demo-
graphic and health-related variables were collected for
descriptive analysis. The survival status of each patient
(i.e. alive or dead) was also recorded at each time point.
Exploratory analyses were conducted on the data to
assess the extent of missing data, frequencies of groups
in categorical variables, possible collinearity between
predictor variables and suitability of the outcome mea-
sures for a multivariate treatment. Categorical variables
with a high number of categories including low-frequency
categories were combined appropriately for analysis to
ensure that each category had a sufficient number of
individuals for analysis. Patterns of correlations between
outcome variables were assessed for suitability for multi-
variate treatment.
Analysis of variance (ANOVA) and multivariate ana-
lysis of variance (MANOVA) were conducted on data
collected at 6 months after the PCI procedure (time
point 1) and 12 months after the PCI procedure (time
point 2), with the outcome measures included in the
MANOVA procedure being those found to be substan-
tively correlated. To avoid over-fitting the models, a
modelling strategy was derived whereby each predictor
variable was initially assessed in a series of uni-variable
models. Variables appearing to be important at this stage
were then carried forward for inclusion in multiple
models, with standard statistics reported from these
models. In the event of a particular predictor variable
being significantly related to the linear combination of
outcome measures, follow-up univariate analyses of
variance (ANOVAs) were conducted to investigate the
sources of such associations.
A series of doubly multivariate repeated measures
analyses of variance was also conducted on the data
to further investigate the effect of the time compo-
nent. A similar modelling strategy was implemented
as for the ANOVA/MANOVA models; with between-
subjects variables initially assessed on a univariable
basis within these models; any variables found to be
of substantive significance were carried forward for
inclusion in a multiple model.
Results
Descriptive and exploratory analysis
Data was collected on 51 patients for this pilot study.
Baseline sample characteristics are summarised descrip-
tively in Table 2.
Exploratory analyses identified a small amount of
missing data on certain predictor variables. The total
amount of missing data was less than 0.5 %. Missing
data on predictor variables only was imputed using
expectation maximisation.
Only one participant self-reported as a user of tobacco.
This variable was not considered further. No evidence
for collinearity was observed between the remaining
independent variables considered for analysis.
Analysis – time point 1 (6 months post PCI)
All patients were recorded as being alive at time point 1.
The pattern of correlations between outcome measures
at time point 1 revealed statistically significant moderate
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negative correlation between the PQ-9 instrument and:
the CD-RISC instrument (r = -0.331; p = 0.018); the men-
tal component summary (MCS) subscale of the SF-12
instrument (r = -0.517; p < 0.001); and the physical com-
ponent summary (PCS) subscale of the SF-12 instrument
(r = -0.506; p < 0.001); implying that a multivariate treat-
ment was appropriate for these outcome measures. The
correlations are illustrated in Fig. 1 (a)–(c).
No significant or substantive correlation was recorded
between the BMQ instrument and the other outcome
measures. Hence a separate univariate analysis was con-
ducted on this outcome.
Univariable models indicated that gender, exercise
levels, cholesterol/lipid levels and weight exhibited at
least some substantively important association with a
linear combination of the PQ-9, CD-RISC, SF12-MCS
and SF12-PCS scales. These variables were carried
forward to a multiple multivariate model including
these outcome measures. The variables age, education,
hypertension, diabetes status, frequency of eating, and
post-intervention readmission did not appear to be
important in univariable models and were not consid-
ered further with respect to these outcome measures.
The multiple model indicated that controlling for
other factors, gender was significantly associated with a
linear combination of outcome measures (Λ = 0.697;
F4,40 = 4.45; p = 0.004). The effect was moderate in mag-
nitude (partial-η2 = 0.303). Follow-up univariate ANO-
VAs indicated that gender differences were grounded in
the PQ-9 scale (F1,44 = 8.85; p = 0.005) and the SF12-PCS
scale (F1,44 = 10.2; p = 0.003). On the PHQ scale, the
mean male score was 13.1 (SD 5.21); the mean female
score was 17.1 (SD 3.57). On the SF12-PCS scales, the
mean male score was 53.1 (SD 9.58); the mean female
score was 44.9 (SD 11.8). Hence males performed signifi-
cantly better than females on both these scales 6 months
after the PCI procedure.
No other factor was found to be statistically significant
in the multiple model; however, some of the remaining
factors indicated a degree of substantive significance.
None of the categorical factors or covariates consid-
ered exhibited any statistically significant or substantive
association with the BMQ outcome measure.
Analysis – time point 2 (12 months post PCI)
Thirteen patients were lost to follow-up between time
points 1 and 2. One patient was confirmed to have
passed away. Twelve patients refused to participate fur-
ther in the study or did not respond to requests; of
these, 10 were known to be alive at time point 2, with
the status of two patients being uncertain.
The pattern of correlations between outcome mea-
sures at time point 2 revealed statistically significant or
near-significant negative correlation between the PHQ
Table 2 summary of baseline sample characteristics
Categorical factors Frequency (valid %)
Gender
Male 41 (80.4 %)
Female 10 (19.6 %)
Highest level of qualification
Primary school 2 (3.9 %)
High school 33 (64.7 %)
TAFE qualification 13 (25.5 %)
Postgraduate degree 3 (5.9 %)
Marital status
Single 3 (5.9 %)
Married 37 (72.5 %)
De facto 4 (7.8 %)
Separated 1 (2.0 %)
Divorced 1 (2.0 %)
Widowed 5 (9.8 %)
Hypertension
Yes 30(58.8 %)
No 21 (41.2 %)
Smoking status
Smoker 1 (2.0 %)
Non-smoker 50 (98.0 %)
Diabetes
Yes 12 (23.5 %)
No 39 (76.5 %)
Exercise frequency
None 3 (5.9 %)
1-3 times per week 14 (27.5 %)
4-6 times per week 6 (11.8 %)
Daily 28 (54.9 %)
Cholesterol level (total above 5.5 mmol/L)
High 35 (70.0 %)
Normal 15 (30.0 %)
Adherence to cardiac rehabilitation
Not at all 18 (36.7 %)
Sometimes 6 (12.2 %)
Often 8 (16.3 %)
Always 17 (34.7 %)
Readmission post intervention
Yes 16 (32.0 %)
No 34 (68.0 %)
Numerical covariates Mean (SD)
Age 72.3 (8.82)
Height (cm) 173.9 (8.34)
Weight (kg) 82.7 (14.0)
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instrument and the CD-RISC instrument (r = -0.611;
p < 0.001); and the PCS subscale of the SF-12
instrument (r = -0.437; p = 0.054). Most other correla-
tions between outcome measures, were also negative
and moderate in magnitude; implying that a multi-
variate treatment was appropriate for all outcome
measures, including the BMQ outcome. Univariable
models indicated that education level and hyperten-
sion exhibited at least some substantively important
association with a linear combination of the PHQ,
CD-RISC, BMQ, SF12-MCS and SF12-PCs scales.
These variables were carried forward to a multiple
model. This model did not indicate either education
level or hypertension to be statistically associated with
a linear combination of the outcome measures.
Repeated measures analysis
Outcome measured recorded at time points 1 and 2 are
summarised in Table 3 below.
Hence a substantive change was recorded in all mea-
sures except the CD-RISC measure between the two
time points. The reduction in PQ-9 scores, and the in-
crease in SF12-MCS scores represent improvements; the
increase in BMQ scores and the reduction in SF12-PCS
scores represent deteriorations. A null model with no
between-subjects factors or covariates indicated that
time point 2 (12-month) scores were significantly different
from time point 1 (6-month scores) on the PHQ outcome
(F1,18 = 143.7; p < 0.001), the MCS outcome (F1,18 = 24.5;
p < 0.001), the PCS outcome (F1,18 = 11.0; p = 0.004) and
the BMQ outcome (F1,18 = 6.33; p = 0.022). Scores on
the CD-RISC outcome were not significantly different
between time points 1 and 2. No between-measures
factors or covariates measured in univariable models
were statistically significant or exhibited substantive
importance.
Discussion
The analysis reveals that men are performing better than
women 6 months after the PCI procedure on a range of
outcome measures, particularly depression (as measured
by the PQ-9 instrument) and physical health (as mea-
sured by the SF-12-PCS instrument). Using the PHQ09
improvements in mood particularly depression has been
associated with improved adherence in cardiac inpatient
cardiac units who were hospitalized for acute coronary
syndrome, heart failure, or arrhythmia in the 6 months
following hospitalisation [25] however, assessment of
gender differences requires further inquiry since the en-
rolment of women in heart studies remains low. In our
study, much of these gender differences have disap-
peared by 12 months. Furthermore, no other grouping
variable discriminates between patients at either 6 or
12 months after PCI. This may be because as a pilot
study, the study is underpowered to detect any such
Fig. 1 a: Correlation between CD-RISC scores and PHQ scores at
time point 1. b: Correlation between SF12-MCS scores and PHQ
scores at time point 1. c: Correlation between SF12-PCS scores and
PHQ scores at time point 1
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effects that may exist; in particular the analysis of time
point 2 data, which was subject to heavy attrition loss.
While significant changes in most outcomes were re-
corded between the two time points, the overall pattern
of improvement is not clear; with the direction of move-
ment being positive for two measures and negative for
two measures. Improvement or deterioration is not more
noticeable in any sub-group than any other. Again, this
may be ascribed to a loss of power as a result of the low
sample size. It is also possible that attrition bias was in-
troduced by the loss of 25.5 % of the sample between 6
and 12 months.
Mood and physical health considerations particularly
for women patients in the first 6 months post-PCI ap-
pears an area for further investigation. It is known that
within Australia, data that specifically addresses women
and CHD is limited [26–28], even in the knowledge that
the traditional risk factors for CVD in women is increas-
ing. Clinically women can present with a wider range of
symptoms, which can lead to delayed diagnosis should
problems arise post-intervention. In addition, psycho-
social factors and conventional CVD risk factors often
coexist (i.e. depression and heart disease). Mental health
problems such as depression give rise to perceived
reduced social support, and can negatively impact of
recovery post PCI. Depression can also become chronic
over time. Care planning related to prodromal symp-
toms and devising a plan of action in collaboration with
patients post PCI is recommended. In addition, assess-
ment of existing and/or required social supports and
pre-existing mental health problems is recommended to
ensure access to required supports post-PCI for patients
in a timely manner.
Limitations of the study
The longitudinal nature of this study, whilst having an
advantage of observing and controlling for differences in
the same cohort of people over a period of time when
compared to cross-sectional study, does have some limita-
tions. Data collection in this study was time-consuming
and resulted in a reduced number of participants complet-
ing surveys at the 12-month time point of the study, with
the resulting smaller sample size at this time point leading
to a reduction in power of analyses conducted at this time
point. The sample size was small, with a small number of
women being represented in the cohort; therefore inter-
pretations of the findings are to be considered conserva-
tively in the context of the pilot study setting. Another
limitation of this study was the use of self-report for
smoking status and in surveys: although each of the mea-
sures used have been tested for reliability and validity, the
nature of surveys relies on participants’ ability to recall
information, answer truthfully, understand the questions
and scales used; and the surveys must have the ability to
remove potential for response bias (i.e. participants will
answer questions in a certain way regardless of the ques-
tion being asked). In this study questionnaires were com-
pleted over the telephone with a researcher. Future
research may consider providing participants with a
paper/online copy of the questionnaire where they would
be able to answer the questions anonymously.
Conclusions
This pilot study has provided insight into the potential
social and physical impacts post-PCI, particularly for
women patients with regard to mood and physical health
with men performing better physically and with mood
6 months post PCI. In consideration of the differences
in symptom presentation between men and women
undergoing cardiac care, interventions need to be tai-
lored in an individual and gender sensitive manner fol-
lowing PCI. Given the paucity of research related to
women following PCI further research into the manage-
ment of mood particularly for women is warranted.
More detailed inquiry related to access/attendance to
secondary prevention is also warranted.
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